"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(mih-vuh-CURE-ee-uhm KLOR-ide)
Mivacron
Class: Muscle relaxant/nondepolarizing neuromuscular blocker

 Action Binds competitively to cholinergic receptors on motor end-plate to antagonize action of acetylcholine, resulting in block of neuromuscular transmission.

 Indications Adjunct to general anesthesia; facilitation of tracheal intubation.

 Contraindications Hypersensitivity to mivacurium or similar agents; use of multidose vials in benzyl alcohol-sensitive patients.

 Route/Dosage

ADULTS: IV Initial dose: 0.15 mg/kg over 5–15 sec. Maintenance: 0.1 mg/kg q 15 min prn or 9–10 mcg/kg/min infusion initially followed by titration (range 1–15 mg/kg/min). CHILDREN 2–12 YR: IV Initial dose: 0.2 mg/kg over 5–15 sec. Maintenance: 14 mcg/kg/min infusion initially followed by titration (range 5–31 mcg/kg/min).

 Interactions

Aminoglycosides, clindamycin, inhalation anesthetics ketamine, parenteral magnesium salts, polypeptide antibiotics, quinidine, quinine, trimethaphan, verapamil: Action of mivacurium potentiated. Azathioprine: Action of mivacurium may be decreased or reversed. Carbamazepine: Shortened action of mivacurium and decreased effectiveness. Theophyllines: Dose-dependent reversal of neuromuscular blockade. Trimethaphan: Prolonged apnea. Verapamil: Enhanced action of mivacurium (eg, respiratory depression). INCOMPATIBILITIES: Alkaline solutions (pH > 8.5).

 Lab Test Interferences None well documented.

 Adverse Reactions

CV: Flushing; hypotension; tachycardia; bradycardia; arrhythmia; hlebitis. DERM: Rash; urticaria; erythema; injection site reaction. RESP: Bronchospasm; wheezing; hypoxemia. OTHER: Dizziness; muscle spasms.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy in children < 2 yr not established. Elderly patients: Neuromuscular blockade may be longer. Cachectic or debilitated patients, patients with neuromuscular disease, burns: Use test dose of £ 0.015–0.02 mg/kg. Cardiovascular disease or allergy/sensitivity (eg, asthma): Administer initial dose of £ 0.15 mg/kg over 60 sec. Obese patients: Use ideal body weight to determine initial dose. Reduced plasma cholinesterase activity: Use drug with great caution, if at all. Renal and hepatic impairment: Duration of action is longer; use lower maintenance doses.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • Administer via IV route only.
  • Administer only under supervision of health care provider familiar with drug actions and possible complications.
  • Ensure that personnel and facilities for resuscitation and life support (tracheal intubation, artificial ventilation, oxygen therapy) re available and have antagonist of drug (anticholinesterase) immediately available.
  • Administer to unconscious patients only.
  • Prepared drug dilutions in compatible solutions may be stored at room temperature for up to 24 hr when protected from ultraviolet light and from temperature extremes.
  • Do not introduce additives into infusion solution.
  • Discard unused portion of diluted drug after each use.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note cardiovascular disease, asthma or other conditions resulting in sensitivity to release of histamine or related mediators; neuromuscular disease; carcinomatosis; renal or hepatic impairment; history of reduced plasma cholinesterase activity.
  • Observe for flushing, hypotension, increases or decreases in heart rate, dizziness or muscle spasms and report to physician.
  • Use nerve stimulator to assess neuromuscular blockade.
  • Maintain adequate hydration and monitor hemodynamic status in patients with clinically significant cardiovascular disease and with asthma or other conditions resulting in sensitivity to release of histamine or related mediators.
  • Perform eye care (eg, artificial tears, covering eye) frequently to prevent corneal drying.
OVERDOSAGE: SIGNS & SYMPTOMS
  Flaccid paralysis, apnea, hypotension

 Patient/Family Education

  • Explain that drug will be administered while patient is unconscious.
  • Advise patient that dizziness or muscle spasms sometimes occur during recovery.

Popularity: 1% [?]


If you're still unable to find appropriate information in the article, please use search form below